Atlantic Coastal Acquisition Corp. II (ACAB) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Atlantic Coastal Acquisit... (ACAB)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

5.77

-5.13 (-47.06%)

At close: Nov 12, 2024, 9:00 PM

undefined% (undefined)

Bid	n/a
Market Cap	46.40M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.13
PE Ratio (ttm)	-44.38
Forward PE	n/a
Analyst	n/a

Ask	n/a
Volume	156,199
Avg. Volume (20D)	15,368
Open	11.11
Previous Close	10.90
Day's Range	5.75 - 11.11
52-Week Range	3.23 - 13.00
Beta	undefined

About ACAB

Atlantic Coastal Acquisition Corp. II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in mobility sector. Atlantic Coastal Acquisition Corp. II was incorporated in 2021 and is based in New York, New York....

[Show more]

Industry Shell Companies

Sector Financial Services

IPO Date Mar 9, 2022

Employees 4

Stock Exchange NASDAQ

Ticker Symbol ACAB

Website https://www.atlanticcoastalacquisition.com

News

1 year ago · businesswire.com

Abpro to Become Publicly Traded via Merger with Atlantic Coastal Acquisition Corp. II

WOBURN, Mass. & NEW YORK--(BUSINESS WIRE)--Abpro Corporation (“Abpro”), a biotechnology company with the mission of improving the lives of those facing severe and life-threatening diseases with next-g...